Citation: Ch. Wang et Sh. Sheu, The effects of the warranty cost on the imperfect EMQ model with general discrete shift distribution, PROD PLAN C, 12(6), 2001, pp. 621-628
Citation: Ch. Wang et Sh. Sheu, Simultaneous determination of the optimal production-inventory and productinspection policies for a deteriorating production system, COMPUT OPER, 28(11), 2001, pp. 1093-1110
Citation: Sh. Sheu et Hs. Weng, Treatment of olefin plant spent caustic by combination of neutralization and Fenton reaction, WATER RES, 35(8), 2001, pp. 2017-2021
Authors:
Ho, KY
Kuo, WR
Chai, CY
Tsai, SM
Sheu, SH
Wu, SC
Juan, KH
Citation: Ky. Ho et al., A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma, LARYNGOSCOP, 111(1), 2001, pp. 131-136
Citation: Wc. Voon et al., Role of intraventricular dispersion of early diastolic filling in indicating left ventricular diastolic dysfunction: Assessment by color M-mode inflow propagation velocity, CARDIOLOGY, 95(3), 2001, pp. 151-155
Citation: Sh. Sheu et Hs. Weng, Determination of free cyanide in sour water at fluid catalytic cracking (FCC) plants, INT J ENV A, 78(2), 2000, pp. 107-115
Authors:
Liang, JC
Yeh, JL
Chiang, LC
Yang, YC
Sheu, SH
Lai, WT
Chen, IJ
Citation: Jc. Liang et al., Labedipinedilol-A: A vanilloid-based alpha/beta-adrenoceptor blocker with calcium entry blocking and long-acting antihypertensive properties, DRUG DEV R, 49(2), 2000, pp. 94-108
Citation: Jp. Jhang et Sh. Sheu, Optimal age and block replacement policies for a multi-component system with failure interaction, INT J SYST, 31(5), 2000, pp. 593-603
Citation: Wc. Voon et al., Role of left ventricular activation sequence in the genesis of isovolumic relaxation flow in the Wolff-Parkinson-White syndrome, AM J CARD, 85(7), 2000, pp. 882
Authors:
Huang, YC
Yeh, JL
Wu, BN
Lo, YC
Liang, JC
Lin, YT
Sheu, SH
Chen, IJ
Citation: Yc. Huang et al., Ferulidilol: A vasodilatory and antioxidant adrenoceptor and calcium entryblocker, with ancillary beta(2)-agonist activity, DRUG DEV R, 47(2), 1999, pp. 77-89